Remove 2021 Remove Epilepsy Remove Patients
article thumbnail

Revised for 2021 — NORML Report Highlights Over 450 Studies Assessing the Therapeutic Efficacy of Cannabis and Cannabinoids

NORML

This updated edition reviews over 450 peer-reviewed studies assessing the safety and efficacy of either whole-plant cannabis or cannabinoids for 23 different patient populations.

article thumbnail

Mississippi: Medical Cannabis Initiative Certified for 2020 Ballot

NORML

The proposed constitutional amendment establishes a state-licensed system of dispensaries to provide cannabis products to qualifying patients. ” The proposal further mandates that state officials begin providing licenses for retailers no later than August 15, 2021. ounces (71 grams) of cannabis per 14-day period.

Epilepsy 264
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Which states allow out-of-state patients to buy medical marijuana?

Veriheal

However, the number of states that will authorize qualified patients from out-of-state medical marijuana programs is still relatively small. . Many places will either permit patients access to dispensaries and/or permit medical cannabis possession within a reasonable amount. Seizures, including those characteristic of epilepsy.

Patients 119
article thumbnail

Nevada veterinarians can now treat patients with certain cannabis products

Cannabis Law Report

September 09, 2021. I certainly hope that other states follow Nevada’s lead and provide reassurances to licensed veterinarians that they can administer CBD or talk about it with patients without fear of facing disciplinary proceedings,” he said. But do medical cannabinoids actually help animal patients? Earlier this year, Gov.

Patients 105
article thumbnail

Will Texas Legalize Recreational Marijuana?

Veriheal

In 2021, the blanket Smoke a joint, lose your license policy was repealed. According to the Texas Government site, Texass Compassionate Use Program (CUP) allows certain physicians to prescribe low tetrahydrocannabinols (THC) cannabis for medical purposes. The Texas medical cannabis program allows for no more than 0.5%

article thumbnail

GW Pharmaceuticals receives approval for EPIDYOLEX® (cannabidiol) from the MHRA for the treatment of seizures associated with tuberous sclerosis complex

Cannabis Law Report

GW was initially granted marketing authorisation for this medicine in the UK in September 2019 as an adjunctive therapy for seizures associated with Lennox Gastaut syndrome (LGS) or Dravet syndrome, in conjunction with clobazam, for patients two years of age and older. TSC is typically diagnosed in childhood. (5)

article thumbnail

France Wants to Experiment With Giving Away Free Medical Cannabis in 2021

Veriheal

The experiment consists of a two-year cycle where up to 3,000 patients will be treated with medical cannabis. The experiment will only last two years long and is set to start with the first prescription in March 2021. This means that patients with prescriptions from a licensed physician may consume and possess cannabis.